Bio Key International (BKYI) Non-Current Deffered Revenue (2016 - 2025)
Bio Key International (BKYI) has disclosed Non-Current Deffered Revenue for 15 consecutive years, with $75146.0 as the latest value for Q3 2025.
- Quarterly Non-Current Deffered Revenue fell 68.78% to $75146.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $75146.0 through Sep 2025, down 68.78% year-over-year, with the annual reading at $196237.0 for FY2024, 593.51% up from the prior year.
- Non-Current Deffered Revenue hit $75146.0 in Q3 2025 for Bio Key International, down from $96729.0 in the prior quarter.
- In the past five years, Non-Current Deffered Revenue ranged from a high of $240664.0 in Q3 2024 to a low of $28296.0 in Q4 2023.
- Historically, Non-Current Deffered Revenue has averaged $88054.9 across 5 years, with a median of $71037.0 in 2021.
- Biggest five-year swings in Non-Current Deffered Revenue: skyrocketed 643.85% in 2024 and later plummeted 68.78% in 2025.
- Year by year, Non-Current Deffered Revenue stood at $67300.0 in 2021, then fell by 22.53% to $52134.0 in 2022, then tumbled by 45.72% to $28296.0 in 2023, then soared by 593.51% to $196237.0 in 2024, then tumbled by 61.71% to $75146.0 in 2025.
- Business Quant data shows Non-Current Deffered Revenue for BKYI at $75146.0 in Q3 2025, $96729.0 in Q2 2025, and $136931.0 in Q1 2025.